Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada.
Nigel S B RawsonDavid J StewartPublished in: ClinicoEconomics and outcomes research : CEOR (2024)
CADTH's "typical timeline" and the pCPA's targets were not met sufficiently to be meaningful. Their processes take too long for cancer drugs.